Fig.3

Estimation of fecal gut-integrity and bacterial translocation markers–(A) Levels of fecal metabolites assessed by ELISA in HCMV infected infants with NC (N = 15 each) and healthy controls (N = 10); (B) Significant ROC curve analysis of fecal gut-integrity markers between HCMV infected infants with NC. Data represented as Median. Statistical significance was calculated by and Kruskal–Wallis test with Dunn’s multiple comparison test; *, p < 0.05; **, p < 0.01, ***, p < 0.001; and ****, p < 0.001